Recent Posts
- NITYR (nitisinone) Tablets for tyrosinaemia type 1 will be available with fully subsidised access on the Life Saving Drugs Program across Australia
- Cycle Pharmaceuticals’ NITYR (nitisinone) tablets receives marketing authorization in Chile
- Longer shelf life for NITYR (nitisinone) tablets for HT-1 in the U.S. granted by the FDA
- Cycle Pharmaceuticals Receives Approval for Updated Infant Administration for NITYR (nitisinone) Tablets for HT-1 in U.S.
- Cycle Pharmaceuticals Receives FDA Approval for Ketorolac Tromethamine Tablets in the U.S.
Archives
- No comments have been published yet.
Find us on Facebook
Archives
Recent Posts
- NITYR (nitisinone) Tablets for tyrosinaemia type 1 will be available with fully subsidised access on the Life Saving Drugs Program across Australia
- Cycle Pharmaceuticals’ NITYR (nitisinone) tablets receives marketing authorization in Chile
- Longer shelf life for NITYR (nitisinone) tablets for HT-1 in the U.S. granted by the FDA
- Cycle Pharmaceuticals Receives Approval for Updated Infant Administration for NITYR (nitisinone) Tablets for HT-1 in U.S.
- Cycle Pharmaceuticals Receives FDA Approval for Ketorolac Tromethamine Tablets in the U.S.
Recent Tweets
-
"Unless you try to do something beyond what you have already mastered, you will never grow." - Ralph Waldo Emerson… twitter.com/i/web/status/1…
14 hours ago -
@enshrined Hey Daryll, please send an email to support@theme-fusion.com and we will connect there.
5 days ago -
@idguy It will come in handy, but you will always have the option to choose to edit front, back end, or both, your choice
6 days ago
Recent Comments